Secondary cytoreductive surgery with HIPEC: a promising therapeutic option for recurrent ovarian cancer

Lancet Oncol. 2024 Dec;25(12):1509-1511. doi: 10.1016/S1470-2045(24)00592-8. Epub 2024 Nov 14.
No abstract available